Exogen

Securing Success with Patent Protection and an IP Edge

Retrieved on: 
Sabato, Settembre 16, 2023
Hydrogen, Communication, Head Injuries, Apple Inc., Data science, Marketing, Electricity, Microsoft, Apple Watch, Computer, Patent, Investment, Risk, Iberdrola, Publishing, News, Software, Advertising, IPhone, GPS, University, Interview, Litigation involving Apple Inc., Skiing, JEV, Research, Broker-dealer, SEDAR, Apple, Growth, Use, Disclaimer, Hydrogen technologies, Carbon, Government, AAPL, Climate change, Traction, Rystad Energy, MSFT, Partnership, File, Bank statement, Information Bridge: Department of Energy Scientific and Technical Information, Crash, OTC, AI, Health, Video game, Renewable energy, Oil, Cryptocurrency, Exogen, EU, AirPods, Avangrid

That's why Jericho Energy Ventures (TSX.V: JEV) (OTC: JROOF) is thrilled to obtain patent approval for its subsidiary’s hydrogen-fueled steam boiler.

Key Points: 
  • That's why Jericho Energy Ventures (TSX.V: JEV) (OTC: JROOF) is thrilled to obtain patent approval for its subsidiary’s hydrogen-fueled steam boiler.
  • These patents not only recognize their innovations but also give them a competitive industry edge.
  • This is the third patent Hydrogen Technologies has in the pipeline as the company begins to receive initial commercial orders.
  • Apple Inc's (NASDAQ: AAPL) new patent application suggests enhancing Crash Detection accuracy by integrating multiple Apple devices, notably using motion sensors in AirPods.

Jericho Energy Ventures Inc.: Unleashing the Power of Green Hydrogen: A Hot Investment Trend

Retrieved on: 
Giovedì, Luglio 13, 2023
Hydrogen, News, Jacobs Solutions, Fortescue Metals Group, Communication, Advertising, Aberdeen City Council, Partnership, EU, Interview, Exogen, Metal, Use, Disclaimer, Marketing, Aluminium, Bank statement, JLM, Risk, JEV, Research, Hydrogen technologies, Recycling, FRA, Carbon, Government, Organization, Steam, Iron, Investment, Engineering, Natural gas, OTC, SEDAR, FFI, CO2, Growth, Transport, Publishing, NYSE, Renewable energy, Security (finance), Norsk Hydro, BP

Jericho Energy Ventures Inc.: Unleashing the Power of Green Hydrogen: A Hot Investment Trend

Key Points: 
  • Jericho Energy Ventures Inc.: Unleashing the Power of Green Hydrogen: A Hot Investment Trend
    The issuer is solely responsible for the content of this announcement.
  • Together, these collaborations signify an industry-wide commitment to sustainable energy practices and signal a promising future for the green hydrogen movement.
  • The HSP3000 features the patented DCC™ boiler technology developed by Hydrogen Technologies, a wholly-owned subsidiary of Jericho Energy Ventures.
  • This partnership underpins the shared commitment to renewable energy, supporting FFI’s global green hydrogen and renewable energy projects, aimed at decarbonizing heavy industries.

Lila® Announces Groundbreaking Partnership with Star Athletics

Retrieved on: 
Giovedì, Luglio 13, 2023
Diamond, Overload, Doha Diamond League, Partnership, Texas Relays, 2019 Doha Diamond League, North Star Athletic Association, Athlete, Running, Bednarek, 2019 World Athletics Championships, Mitchell, World Athletics, Hayward Field, Sport, Dietary supplement, Exogen, Olympic

ORLANDO, Fla., July 13, 2023 /PRNewswire/ -- Star Athletics continues to dominate the track and field world with exceptional performances, and their recent success at the USATF Outdoor Championships at Hayward Field further solidifies their position as a powerhouse track club. With the event serving as a crucial qualifier for the World Athletics Championships, Star Athletics have once again showcased their extraordinary talent. Fueling their remarkable achievements is a groundbreaking partnership with Lila, a sports technology company, and their revolutionary product, Exogen wearable resistance.

Key Points: 
  • With the event serving as a crucial qualifier for the World Athletics Championships, Star Athletics have once again showcased their extraordinary talent.
  • Fueling their remarkable achievements is a groundbreaking partnership with Lila, a sports technology company, and their revolutionary product, Exogen wearable resistance.
  • Another standout athlete from Star Athletics, the Olympic silver medalist, Kenny Bednarek, delivered in the men's 200m, claiming a second-place finish.
  • Under the guidance of Dennis Mitchell, Star Athletics has harnessed the power of Exogen to redefine the boundaries of speed.

Lila® Partners One FC Heavyweight Champion Arjan Bhullar For Upcoming Title Defence

Retrieved on: 
Martedì, Febbraio 21, 2023
Bhullar, Lila, Athlete, Greek Olympics, ONE Fight Night 8, Exogen, Sport, Pedigree, NFL, Movement, Amazon, ONE, Partnership, Athens, Multimedia, Wrestling, Rail transport, Aldo Dolcetti

VANCOUVER, BC, Feb. 21, 2023 /PRNewswire/ -- Lila, a sports technology company pioneering wearable resistance and digital performance analytics, has signed a partnership with ONE heavyweight champion Arjan Bhullar for his upcoming title defence on 24 March 2023 in Singapore.

Key Points: 
  • VANCOUVER, BC, Feb. 21, 2023 /PRNewswire/ -- Lila, a sports technology company pioneering wearable resistance and digital performance analytics, has signed a partnership with ONE heavyweight champion Arjan Bhullar for his upcoming title defence on 24 March 2023 in Singapore.
  • The partnership will see Bhullar incorporating Exogen® wearable resistance into his training camp.
  • "Coming off surgery for a bicep tendon tear last year, I was looking for tools to aid my recovery.
  • Bhullar faces Anatoly Malykhin, the current ONE light heavyweight and interim ONE heavyweight world champion, in a unification bout, ONE Fight Night 8, streamed live on Amazon Prime.

Lila® Partners With House of Athlete for 2023 NFL Combine Program Bringing Their Wearable Resistance Technology to the US

Retrieved on: 
Mercoledì, Gennaio 18, 2023
Lila, NFL, Aldo Dolcetti, World Athletics Championships, Education, House, Partnership, Exogen, NFL Scouting Combine, Canada national team, United States national team, Athlete, Sports equipment, Sport, HOA, Science

TAMPA, Fla., Jan. 18, 2023 /PRNewswire/ -- Lila®, a sports technology company, is partnering with Florida-based House of Athlete (HOA), a lifestyle and wellness brand founded by Brandon Marshall, to supply their Exogen® line of wearable resistance for HOA's upcoming 2023 NFL Combine Training Program.

Key Points: 
  • TAMPA, Fla., Jan. 18, 2023 /PRNewswire/ -- Lila®, a sports technology company, is partnering with Florida-based House of Athlete (HOA), a lifestyle and wellness brand founded by Brandon Marshall, to supply their Exogen® line of wearable resistance for HOA's upcoming 2023 NFL Combine Training Program.
  • The partnership will see Lila's flagship product, Exogen wearable resistance, incorporated into aspects of HOA's pre-draft training across Weston and Tampa with a focus on athlete speed development.
  • Joseph Dolcetti, Founder of Lila commented: "House of Athlete is one of the most innovative, movement-focused athlete development programs I've seen in the past three decades and we're honoured they choose us as their Wearable Resistance Partner for their 2023 NFL Combine program.
  • Our Exogen wearable resistance technology is clearly establishing itself as one of the most important advances in speed performance and technical conditioning."

Miach Orthopaedics Appoints Patrick McBrayer President & CEO

Retrieved on: 
Mercoledì, Settembre 7, 2022
Biotechnology, Surgery, Medical Devices, Health, Physical Therapy, National, Femur, CEO, Technology, Rupture, Spine, Research, McBrayer, Regulation of tobacco by the U.S. Food and Drug Administration, BEAR, Tibia, Army of the United States, Regenerative medicine, Thomas Edison, Boston, Leg, Implant, Blood, Â, Food, ACell, LinkedIn, De novo, ACL, Bridge, Patient, Instagram, Leadership, Use, National Football League Players Association, Hospital, Biotechnology, Twitter, MRI, Johnson & Johnson, Association, Infantry, NFL, Orthopedic surgery, United States service academies, Exogen, Dentistry, Management, Medical device, Miach, Facebook, Insming

Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR) Implant, today announced healthcare industry veteran Patrick McBrayer has been appointed president and chief executive officer.

Key Points: 
  • Miach Orthopaedics, Inc. , a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR) Implant, today announced healthcare industry veteran Patrick McBrayer has been appointed president and chief executive officer.
  • The team at Miach Orthopaedics has made tremendous progress over the last year in driving market adoption of the BEAR Implant for ACL restoration, said Patrick McBrayer, president and CEO, Miach Orthopaedics.
  • McBrayer replaces Christopher Joyce, who served as interim president and CEO since Martha Shadan left the company in June.
  • Prior to joining Miach, McBrayer served as president and CEO of ACell, AxioMed Spine Corporation, Exogen and Osteotech; CEO of Xylos Corporation; and co-founder of Transave (now Insmed).

Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

Retrieved on: 
Martedì, Aprile 26, 2022
Projection, Government, Loss, GAAP, Organic acid, IPO, U.S. Securities and Exchange Commission, COVID-19, Security (finance), Twitter, Regulation of tobacco by the U.S. Food and Drug Administration, Research, Conversation, Annual report, Exogen, Food, Analysis, EBITDA, Depreciation, Securities Act of 1933, Patient, Terminology, Risk, Innovation, Tissue, LinkedIn, Mission statement, Growth, Evidence-based medicine, Securities Exchange Act of 1934, Review, Hyaluronic acid, Failure, BV, Company, SEC, Forward-looking statement, Investment, Income, HA, Financial condition report, Physician, FDA, Result, Accounting, Acquisition, Time, Risk management, Financial services, Bank, Audit, Insurance

This press release presents preliminary results, for the periods presented, of Bioventus Inc., including Bioventus LLC, the predecessor of Bioventus Inc. for financial reporting purposes.

Key Points: 
  • This press release presents preliminary results, for the periods presented, of Bioventus Inc., including Bioventus LLC, the predecessor of Bioventus Inc. for financial reporting purposes.
  • Included above are certain estimated preliminary unaudited financial results for the first quarter of 2022.
  • Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP.
  • Our management also uses Adjusted EBITDA for planning purposes, including the preparation of our annual operating budget and financial projections.

Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

Retrieved on: 
Martedì, Marzo 1, 2022
GLOBE, EFC, Chronic pain, Physician, Pain management, Government, Risk, Regulation of tobacco by the U.S. Food and Drug Administration, Twitter, SEC, Securities Exchange Act of 1934, Pain, Failure, Investment, Smartphone, Security (finance), Projection, Family, Annual report, Tissue, Use, COVID-19, Organic acid, HA, Company, In the Library of Horrific Events, U.S. Securities and Exchange Commission, Friends, Review, Adoption, Food, LinkedIn, Evidence-based medicine, Terminology, Exogen, FDA, US Foods, Nasdaq, Securities Act of 1933, Patient, Forward-looking statement, Technology, Drug Quality and Security Act, Hyaluronic acid, Goal, PNS, Innovation, Research, American Academy of Craniofacial Pain, Pharmaceutical industry

StimRouter is a minimally invasive neuromodulation medical device consisting of a thin, implanted lead with conductive electrode, external electric field conductor (E-EFC), and StimRouter Plus Mobile Application.

Key Points: 
  • StimRouter is a minimally invasive neuromodulation medical device consisting of a thin, implanted lead with conductive electrode, external electric field conductor (E-EFC), and StimRouter Plus Mobile Application.
  • Thousands of patients have successfully used the StimRouter Neuromodulation system, and the newly cleared StimRouter system provides the same clinically proven, long-term pain relief while significantly improving the patients control and user experience.
  • The upgraded StimRouter technology and associated mobile application will help improve the experiences of patients who find pain relief through this innovative technology.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Bioventus Appoints Mark Singleton as Chief Financial Officer

Retrieved on: 
Lunedì, Febbraio 28, 2022
GLOBE, Physician, Government, Achievement, Purdue University, Risk, Twitter, Regulation of tobacco by the U.S. Food and Drug Administration, Time, Securities Exchange Act of 1934, EMEA, Failure, Investment, Security (finance), Projection, Bachelor of Science, Annual report, Tissue, COVID-19, Organic acid, HA, Company, Business, U.S. Securities and Exchange Commission, Review, Acquisition, Food, LinkedIn, Evidence-based medicine, Master of Business Administration, Terminology, Exogen, Leadership, FDA, Securities Act of 1933, Nasdaq, Patient, Forward-looking statement, Drug Quality and Security Act, Hyaluronic acid, Business administration, Innovation, Research, SEC, Management, Risk management, Teleflex, Finance, Science

DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it has appointed Mark Singleton as the Companys Senior Vice President, Chief Financial Officer and Principal Accounting Officer, effective March 21, 2022.

Key Points: 
  • DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, today announced that it has appointed Mark Singleton as the Companys Senior Vice President, Chief Financial Officer and Principal Accounting Officer, effective March 21, 2022.
  • Mr. Singleton brings to Bioventus more than two decades of experience in operational finance and mergers & acquisitions at large and multi-national organizations.
  • He has demonstrated a strong track record of achievement during his time at both Teleflex and Lenovo/IBM, commented Ken Reali, Bioventus chief executive officer.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

Retrieved on: 
Martedì, Gennaio 11, 2022
Securities Exchange Act of 1934, Forward-looking statement, Patient, Research, Conversation, LinkedIn, Organic acid, Financial condition report, SEC, Regulation of tobacco by the U.S. Food and Drug Administration, COVID-19, HA, Growth, Risk, Government, Exogen, GLOBE, Review, U.S. Securities and Exchange Commission, Nasdaq, Tissue, Company, Investment, Result, Evidence-based medicine, Innovation, Projection, Food, Hyaluronic acid, Twitter, FDA, Mission statement, Annual report, Security (finance), Securities Act of 1933, Failure, Physician, Analysis, Terminology, Acquisition, Risk management, Audit

DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, announced today preliminary revenue results for the fourth quarter and full-year 2021.

Key Points: 
  • DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, announced today preliminary revenue results for the fourth quarter and full-year 2021.
  • Preliminary, unaudited revenue for the fourth quarter 2021 is expected to be in the range of $128.5 to $131.5 million, reflecting 30% to 33% growth compared to the prior-year period.
  • Preliminary, unaudited full-year 2021 revenue is expected to be in the range of $429 to $432 million, reflecting an increase of approximately 34% compared to full-year 2020.
  • Included above are certain estimated preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021.